The Jyske Bank Group forecasts a pre-tax profit at the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The Jyske Bank Group forecasts a pre-tax profit at the level of DKK 3.0bn for the first half of 2014
  • The Jyske Bank Group forecasts a pre-tax profit at the level of DKK 3.0bn for the first half of 2014
  • New home loan products in the amount of approximately DKK 9.0bn
  • Jyske Bank launches Jyske F3 and Jyske F5 home loan products
  • BRFkredit presents its interim financial report for the first quarter of 2014
  • Capital increase in BRFkredit of DKK 1.0bn
  • Statement of preliminary fair value and a bargain purchase in relation to BRFkredit

In connection with this announcement, Anders Dam, Managing Director and CEO states: 

"The profit for the first half of 2014 is expected to be historically high. 

This profit is to be assessed and viewed in the light of the recognition of DKK 2.4bn as income in the form of a bargain purchase in connection with the merger with BRFkredit and that the accounting estimates will be subject to reassessment and alignment at Jyske Bank as well as at BRFkredit. The total effect of such adjustments will ad up to about DKK -1.3bn. 

Hence the profit for the first half of 2014 is to a considerable degree affected by circumstances of a non-recurring nature. 

The integration with BRFkredit is progressing according to plan," concludes Anders Dam. 

Jyske Bank Group forecasts a pre-tax profit at the level of DKK 3.0bn for the first half of 2014

In connection with the merger with BRFkredit and the alignment of accounting policies, certain assets and liabilities are and will be subject to reassessment. Particularly assets and liabilities, comprising in particular the banks property, unlisted shares and loans, involving managerial assessment have been reassessed. 

Reassessment of these assets and liabilities result in expenses of a non-recurring nature in the range of DKK 400m to 500m at Jyske Bank. Therefore, the Jyske Bank Group forecasts a pre-tax profit of DKK 3.0bn for the first half of 2014 provided market interest rates do not change. 

New home loan products in the amount of approximately DKK 9.0bn

Jyske Bank is still seeing strong interest in its new home loan products, and at today's date Jyske Bank has granted loans totalling approximately DKK 9.0bn since the launch in mid-December 2013. 

Jyske Bank launches Jyske F3 and Jyske F5 home loan products

As a consequence of the strong demand, Jyske Bank will in early June launch new Jyske F3 and Jyske F5 home loan products. The new products will, among other things, offer maturities of up to 30 years, be offered as interest-only loans for a period of up to 10 years, and they will offer financing of up to 80% and competitive pricing. 

The BRFkredit Group presents its interim financial report for the first quarter of 2014

On 30 April 2014, the Jyske Bank Group released its interim financial report for the first quarter of 2014. After the merger of BRFkredit and Jyske Bank on 30 April 2014, the BRFkredit Group is now a part of the Jyske Bank Group.  

Summary of the BRFkredit Group's interim financial report for the first quarter of 2014: 

  • Net interest and fee income amounted to DKK 539m against DKK 464m in the first quarter of 2013.
  • Loan impairment charges and provisions for guarantees amounted to DKK 965m against DKK 82m in the first quarter of 2013.
  • The profit before tax amounted to DKK -837m against DKK 22m in the first quarter of 2013.
  • Core income amounted to DKK 408m against DKK 385m in the first quarter of 2013.
  • Core earnings before impairment charges and banking operations amounted to DKK 158m against DKK 146m in the first quarter of 2013.
  • Earnings from investment portfolios amounted to DKK 19m against DKK 44m in the first quarter of 2013.
  • Loans and advances amounted to DKK 211bn against DKK 209bn at end-2013.
  • The solvency ratio came to 15.6% against 16.6% at end-2013. 

The results reflect a positive development of core income and core earnings before impairment charges and banking operations. 

The results were adversely affected by the Danish Financial Supervisory Authority's (FSA) new guidelines on individual impairment charges and provisions published in March 2014. BRFkredit has interpreted and implemented the new guidelines in the first quarter of 2014, which resulted in a negative operational effect in the amount of DKK 822m in the BRFkredit Group, distributed between BRFkredit with DKK 621m and BRFkredit Bank with DKK 201m. 

In relation to the FSA's new guidelines on individual impairment charges and provisions, BRFkredit's interpretation and implementation ensures consistency in the principles applied in the Jyske Bank Group. 

The profit for the period in the amount of DKK -653m and the additional activation of deferred tax of DKK 169m had an adverse effect on BRFkredit's capital base, and the solvency ratio fell to 15.6% against 16.6% at end-2013. 

Capital increase in BRFkredit of DKK 1.0bn

Capital planning at BRFkredit is based on a solvency ratio that is sufficient to support plans of business volume growth and to ensure compliance with legal and internal capital requirements. For adoption at an extraordinary general meeting of BRFkredit, the motion is proposed to increase the capital by issuing 10,000,000 shares at a nominal value of DKK 100. The increase of the capital base by DKK 1bn will, in isolation, increase the solvency ratio to 17.2%. 

Statement of preliminary fair value and a bargain purchase in relation to BRFkredit

On 30 April 2014, Jyske Bank took over all shares in BRFkredit a/s. The preliminary fair value of the assets and obligations taken over was as at the day of acquisition calculated at DKK 241.8bn and DKK 232.3bn, respectively. 

Fair value of the net assets taken over amounts to DKK 9.5bn, and hence it exceeded the acquisition price of DKK 7.1bn. The difference, termed bargain purchase, has been calculated at DKK 2.4bn. The bargain purchase will be recognised as income in the second quarter of 2014 under other operating income. 

Other information

For further information, please see http://www.jyskebank.dk/ www.jyskebank.info and www.brf.dk . 

On www.jyskebank.info you will find an interview with Anders Dam, Carsten Tirsbæk Madsen and Birger K. Nielsen, detailed financial information as well as Jyske Bank's Annual Report 2013 and Risk and Capital Management 2013, which give further information about Jyske Bank’s internal risk and capital management as well as regulatory issues, including a description of the most important risks and elements of uncertainty that may affect Jyske Bank. 

Contact persons concerning this announcement are Anders Dam, Managing Director and CEO, (+45 89 89 20 01) and Birger K. Nielsen, CFO, (+45 89 89 64 44). 

On www.brf.dk you will find detailed financial information as well as BRFkredit's Annual Report 2013 and Risk and Capital Management 2013, which give further information about BRFkredit’s internal risk and capital management as well as regulatory issues, including a description of the most important risks and elements of uncertainty that may affect BRFkredit. 

The contact person concerning the interim financial report for the first quarter of 2014 for the BRFkredit Group is Carsten Tirsbæk Madsen, CEO of BRFkredit, +45 45 26 28 71 and mobile +45 40 25 88 74. 

The Jyske Bank Group's interim financial report for the first half of 2014 will be published on 19 August 2014.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 81

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 25

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 106

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 135

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 116

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 191

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Honeywell Aerospace Faces Class Action: Deadline Looms

Updated Category News Views 93

Navigating the Legal Storm with Honeywell Look, investors never have it easy, and when lawsuits start flying like today's news about Honeywell Aerospace, you better have your wits about you. Now here comes Kahn Swick & Foti, LLC, ringing the alarm bells. Any holders of Honeywell Aerospace stocks between late June and early September of '26 are squarely in the spotlight....

Continue Reading

Top 5 Most Recently Viewed Articles

Beijing's EV Export Rules Impact NIO and Li Auto Stocks

Updated Category News Views 298

Beijing Implements Stricter EV Export Regulations Affecting Stocks Recently, Chinese electric vehicle (EV) stocks NIO (NYSE: NIO) and Li Auto (NASDAQ: LI) have experienced a notable decline following announcements regarding new regulations by Beijing aimed at tightening the export of EVs. New Export Permit Requirements Effective from January 1, the Ministry of Commerce in...

Continue Reading
OceanaGold Set to Announce Q2 2025 Financial Results Soon

Updated Category News Views 122

Upcoming Financial Results from OceanaGold OceanaGold Corporation (TSX: OGC, OTCQX: OCAND) is gearing up to release its operational and financial results for the second quarter of 2025. This detailed announcement will take place after the market close, and it’s expected to shed light on the company's recent performance and highlight future prospects. Conference Call...

Continue Reading
India's July Industrial Growth Surpasses Expectations by 0.1%

Updated Category News Views 121

India's Industrial Output Shows Promising Growth in July Recent government data reveals that India's industrial output rose by a noteworthy 4.8% year-on-year in July. This figure has drawn attention since it slightly exceeds economists' forecast of 4.7% for the same month. These growing numbers reflect a resilient manufacturing sector that is steadily recovering....

Continue Reading
VideoAmp Extends Partnership with Paramount Global for Measurement

Updated Category News Views 180

VideoAmp and Paramount Global Strengthen Their Collaboration VideoAmp, a pioneering media measurement company, has recently announced the continuation of its long-term collaboration with Paramount Global. This partnership reflects a commitment to evolving the advertising landscape with precise audience insights. Comprehensive Audience Measurement This renewal provides...

Continue Reading
Empire State Realty Trust Delivers Strong Q3 Performance and Guidance

Updated Category News Views 53

Empire State Realty Trust Shows Remarkable Q3 Financial Results Empire State Realty Trust (NYSE: ESRT) demonstrated impressive financial outcomes in its most recent earnings call for the third quarter of 2024, surpassing analyst expectations significantly. The real estate investment trust revealed a Funds From Operations (FFO) totaling $69 million, translating to $0.26...

Continue Reading